tiprankstipranks
Trending News
More News >

Scott Jordan Insider Profile

11 Followers
Scott Jordan, CBO at Decoy Therapeutics, holds 300.00K shares in Zomedica (Ticker: ZOMDF), holds 31.61K shares in Decoy Therapeutics (Ticker: DCOY). Most recently, Scott Jordan Bought ― shares of Zomedica on Mar 19, 2025 for an estimated value of $18.00K.
tipranks
Scott Jordan

Scott Jordan
Decoy Therapeutics (DCOY)
CBO

Ranked #23,211 out of 106,131 Corporate Insiders

Profitable Transactions

100%
2 out of 2 Profitable Transactions

Average Return

+114.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$60K
65.29%
34.71%
A breakdown of Scott Jordan's holdings

Insider Roles

Zomedica
(ZOMDF)
CFO
Decoy Therapeutics
(DCOY)
CBO
Roles that Scott Jordan holds in companies

Most Profitable Insider Trade

Stock:
Decoy Therapeutics
(DCOY)
Rating:Informative Buy
Date:Feb 18, 2020 - Feb 18, 2021
Return:+158.80%
The most profitable trade made by Scott Jordan

Scott Jordan's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Decoy Therapeutics
Feb 18, 2020
CBO
Informative Buy
10.17K
$20.89K
Zomedica
Mar 19, 2025
CFO
Informative Buy
18.00K
$39.30K
List of latest transactions for each holding click on a transaction to see Scott Jordan's performance on stock

Scott Jordan insider profile FAQ

What is the percentage of profitable transactions made by Scott Jordan?
The percentage of profitable transactions made by Scott Jordan is 100%.
    What is the average return per transaction made by Scott Jordan?
    The average return per transaction made by Scott Jordan is 114.40%.
      What stocks does Scott Jordan hold?
      Scott Jordan holds: DCOY, ZOMDF stocks.
        What was Scott Jordan’s latest transaction?
        Scott Jordan latest transaction was an Informative Buy of $18.00K.
          What was Scott Jordan's most profitable transaction?
          Scott Jordan’s most profitable transaction was an Informative Buy of DCOY stock on February 18, 2020. The return on the trade was 158.80%.
            What is Scott Jordan's role in Decoy Therapeutics?
            Scott Jordan's role in Decoy Therapeutics is CBO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.